D Greenwood, J Andrew. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Drug Resistance, MicrobialDrug SynergismDrug Therapy, CombinationEscherichia coli/drug effectsKlebsiella pneumoniae/drug effectsNalidixic Acid/administration & dosageNalidixic Acid/pharmacologyNalidixic Acid/therapeutic useNephelometry and TurbidimetryProteus mirabilis/drug effectsPseudomonas aeruginosa/drug effectsRifampin/administration & dosageRifampin/pharmacologyRifampin/therapeutic useUrinary Bladder/microbiologyUrinary Tract Infections/drug therapy
Substances： See more » Nalidixic AcidRifampin
Year: 1978 PMID： 101503 DOI： 10.1093/jac/4.6.533
Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790